The flow of our economy often dictates change at a moment’s notice. We facilitate responsiveness and an investment strategy that builds upon our vast network of established partnerships. As opportunistic investors, our venture approach is founded upon evaluating early-stage to mid-stage companies, initially investing anywhere from $2MM to $10MM. Our hybrid investment model provides unparalleled flexibility to our investors - by allowing them to invest on either a deal-by-deal basis or a committed fund structure.
We seek visionary entrepreneurs developing market-transforming products or technologies, who also share our values. We want to be the very best partners and help drive growth, provide mentorship and work with some of the most creative minds. Our team – comprised of former executives and entrepreneurs – provides access to leadership expertise, strategic guidance and insights in innovation. Our focus is our commitment to help entrepreneurs build and grow innovative and enduring technology companies. Over the past two decades, our main investment focus has centered on privately-held companies, primarily in the Biotechnology, Medical Devices, Semiconductor Design, Data Analytics, and Mobile Platforms.
Partners | Strategy
We also consider our investors, our partners, and as such, provide equally strategic guidance. Our investors have the opportunity to invest alongside institutional investors and first-tier venture capital firms. We are transparent with our investors and meet with our partners every year to share the expectations of our portfolio companies. Through our vast networks and partnerships, we are able to offer our investors a myriad of prospective investment opportunities, choosing companies developing market-transforming products or technologies.